Prognostic value of [18F]-FDG PET/CT in patients with meta-static breast cancer treated with cyclin-dependent inhibitors

OBJECTIVE: The addition of cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) to endocrine therapy impressively improved the outcome of patients with hormone receptor-positive metastatic breast cancer. Despite their great efficacy, not all patients respond to treatment and many of them develop acquire...

Descripción completa

Detalles Bibliográficos
Autores principales: Annovazzi, Alessio, Rea, Sandra, Maccora, Daria, Pizzuti, Laura, Ferretti, Gianluigi, Vici, Patrizia, Cappuzzo, Federico, Sciuto, Rosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376695/
https://www.ncbi.nlm.nih.gov/pubmed/37519806
http://dx.doi.org/10.3389/fonc.2023.1193174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376695/
https://www.ncbi.nlm.nih.gov/pubmed/37519806
http://dx.doi.org/10.3389/fonc.2023.1193174

Ejemplares similares